Competitive CYP2C9 Inhibitors: Enzyme Inhibition Studies, Protein Homology Modeling, and Three-Dimensional Quantitative Structure-Activity Relationship Analysis
- 1 April 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 59 (4) , 909-919
- https://doi.org/10.1124/mol.59.4.909
Abstract
This study describes the generation of a three-dimensional quantitative structure activity relationship (3D-QSAR) model for 29 structurally diverse, competitive CYP2C9 inhibitors defined experimentally from an initial data set of 73 compounds. In parallel, a homology model for CYP2C9 using the rabbit CYP2C5 coordinates was built. For molecules with a known interaction mode with CYP2C9, this homology model, in combination with the docking program GOLD, was used to select conformers to use in the 3D-QSAR analysis. The remaining molecules were docked, and the GRID interaction energies for all conformers proposed by GOLD were calculated. This was followed by a principal component analysis (PCA) of the GRID energies for all conformers of all compounds. Based on the similarity in the PCA plot to the inhibitors with a known interaction mode, the conformer to be used in the 3D-QSAR analysis was selected. The compounds were randomly divided into two groups, the training data set (n = 21) to build the model and the external validation set (n = 8). The PLS (partial least-squares) analysis of the interaction energies against the Ki values generated a model with r2 = 0.947 and a cross-validation of q2 = 0.730. The model was able to predict the entire external data set within 0.5 log units of the experimentalKi values. The amino acids in the active site showed complementary features to the grid interaction energies in the 3D-QSAR model and were also in agreement with mutagenesis studies.Keywords
This publication has 33 references indexed in Scilit:
- Arginines 97 and 108 in CYP2C9 Are Important Determinants of the Catalytic FunctionBiochemical and Biophysical Research Communications, 2000
- Identification of Amino Acid Substitutions that Confer a High Affinity for Sulfaphenazole Binding and a High Catalytic Efficiency for Warfarin Metabolism To P450 2C19Biochemistry, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samplesXenobiotica, 1998
- The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An NMR StudyBiochemistry, 1997
- The Substrate Binding Site of Human Liver Cytochrome P450 2C9: An Approach Using Designed Tienilic Acid Derivatives and Molecular ModelingBiochemistry, 1995
- Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studiesJournal of Medicinal Chemistry, 1993
- Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR ProblemsQuantitative Structure-Activity Relationships, 1993
- D‐Optimal Designs in QSARQuantitative Structure-Activity Relationships, 1993
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985